Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (151-160 of 565) with videos related to

Pageof 57
Sort By:
The International Journal of Neuropsychopharmacology|April 9, 2019
Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED TrialsManish K Jha, Charles South, Jay Trivedi, et al.
Journal of Affective Disorders|March 8, 2006
Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension studyE Sherwood Brown, Dana C Perantie, Nafisa Dhanani, et al.
Pharmacogenetics and Genomics|September 3, 2009
Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatientsGonzalo Laje, Andrew S Allen, Nirmala Akula, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2009
Validation of depression screening scales in patients with CKDS Susan Hedayati, Abu T Minhajuddin, Robert D Toto, et al.
Clinical EEG and Neuroscience|February 3, 2005
High frequency EEG activity during sleep: characteristics in schizophrenia and depressionJanet L Tekell, Robert Hoffmann, William Hendrickse, et al.
Journal of Affective Disorders|May 19, 2007
Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovationT Michael Kashner, Steven S Henley, Richard M Golden, et al.
Neuropsychiatric Disease and Treatment|June 24, 2008
What moderator characteristics are associated with better prognosis for depression?Madhukar H Trivedi, David W Morris, Ji-Yang Pan, et al.
Journal of Affective Disorders|December 16, 2014
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED reportSharon C Sung, Stephen R Wisniewski, James F Luther, et al.
The Journal of Clinical Psychiatry|December 31, 2015
Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D reportLee Baer, Madhukar H Trivedi, Ilana Huz, et al.
The Journal of Clinical Psychiatry|August 29, 2018
Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major DepressionCharles R Conway, Arun Kumar, Willa Xiong, et al.
Pageof 57

Showing results (151-160 of 565) with videos related to

Sort By:
Pageof 57
The International Journal of Neuropsychopharmacology|April 9, 2019
Prediction of Acute-Phase Treatment Outcomes by Adding a Single-Item Measure of Activity Impairment to Symptom Measurement: Development and Validation of an Interactive Calculator from the STAR*D and CO-MED TrialsManish K Jha, Charles South, Jay Trivedi, et al.
Journal of Affective Disorders|March 8, 2006
Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension studyE Sherwood Brown, Dana C Perantie, Nafisa Dhanani, et al.
Pharmacogenetics and Genomics|September 3, 2009
Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatientsGonzalo Laje, Andrew S Allen, Nirmala Akula, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2009
Validation of depression screening scales in patients with CKDS Susan Hedayati, Abu T Minhajuddin, Robert D Toto, et al.
Clinical EEG and Neuroscience|February 3, 2005
High frequency EEG activity during sleep: characteristics in schizophrenia and depressionJanet L Tekell, Robert Hoffmann, William Hendrickse, et al.
Journal of Affective Disorders|May 19, 2007
Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovationT Michael Kashner, Steven S Henley, Richard M Golden, et al.
Neuropsychiatric Disease and Treatment|June 24, 2008
What moderator characteristics are associated with better prognosis for depression?Madhukar H Trivedi, David W Morris, Ji-Yang Pan, et al.
Journal of Affective Disorders|December 16, 2014
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED reportSharon C Sung, Stephen R Wisniewski, James F Luther, et al.
The Journal of Clinical Psychiatry|December 31, 2015
Prevalence and impact of obsessive-compulsive symptoms in depression: a STAR*D reportLee Baer, Madhukar H Trivedi, Ilana Huz, et al.
The Journal of Clinical Psychiatry|August 29, 2018
Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major DepressionCharles R Conway, Arun Kumar, Willa Xiong, et al.
Pageof 57